Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PSYCF INSTAGRAM https://www.instagram.com/psychedwellnessltd/
Slow & non eventful week in the mushroom sector.
APR 1, 2022 1:02 PM EDT
Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?
TheStreet: Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?.
https://www.thestreet.com/technology/biotech-stocks-are-cheap-is-it-time-for-blockbuster-m-a
I just saw this link... check out entire video
Looks like the design I voted for wins!!
That will be good
They have the people to do that but it appears they are strategically waiting to unleash the hounds at a Perfect time!
Yes...but it didn't reach the masses,
they need to use PR Newswire and not all those
rinky dink POS sites!
It's as simple as that. Look at the followers here.
We don't have any!
I am amazed we are not seeing huge interest after that last news release. The news release showed the enormous and realistic potential of the Amanita Muscaria & AME-1
I was looking at it from a marketing perspective... something that would catch your eye and grab your attention.
It's a perfect example of how people can look at the same thing and have such a different view.
It's all good tho. :)
Joey Jones just talked about shrooms for PTSD
on Fox news. This is gonna be huge
I picked #2 myself...I just thought
it has a calmer look.
I can't believe all these people on Twitter are picking #2 when Every single person I showed (about 10 peeps) including myself.... picked #1.
WOW ... I'm amazed at this result!
This is a Very Significant discovery! Psyched Wellness could become a Major Disruptor within Multiple medical fields! ....MULTIPLE!!!
Psyched Wellness and the National Research Council of Canada (NRC) are pleased to announce preliminary data from studies demonstrating that AME-1 may be a neuroprotective agent.
— Psyched Wellness (@PsychedWellness) March 24, 2022
Read more below:https://t.co/RikIprmyh0$PSYC $PSYC.C pic.twitter.com/5cQ8FqW8lW
Long read but great info https://www.pnas.org/doi/10.1073/pnas.0915139107
.11 The Run has Begun!$$$ ( PSYCF ) = Shroom-Boom Baby!!! I'm expecting Big Gains today!! :)
Americans, we are coming to you!
— Psyched Wellness (@PsychedWellness) March 17, 2022
Commercialization is a huge step forward. The long-awaited launch of AME-1 in the USA is scheduled for this Spring. We are fully cashed up and ready to execute our plan. $PSYC $PSYC.C pic.twitter.com/TXoy20L8wT
Go to https://www.amanitadreamer.net/ learn about our shroom.
Register for the new course to see the potential of THE MOTHER OF ALL MUSHROOMS!... (AMANITA MUSCARIA)
PSYCF
Up only 15% today .11... maybe we'll do better tomorrow! :)
L2 was going Crazy at end of day! Bid .10 x Ask .11
Something Huge is brewing here!! I'm glad my boat is fully loaded!
HOLD ON TIGHT!!! WE'RE ABOUT TO BLAST-OFF!!!!!
PSYCF
Looking good today... could be a Break-OUT week!!
Close up another 16% today to close at .10
David John Nutt (born 16 April 1951) is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep.
Yahoo
Newsfile
Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1
Newsfile Corp.
September 21, 2021, 7:30 am
Toronto, Ontario--(Newsfile Corp. - September 21, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce it has initiated first steps towards a clinical sleep study for a structure/function claim for the Company's proprietary extract from Amanita Muscaria mushrooms, AME-1.
The study will be led by Psyched Wellness's Board member and Head of the Company's Scientific Committee, Professor David Nutt, a psychiatrist and the Edmond J. Safra Professor of psychopharmacology at the Imperial College London and the Chair of the Scientific Advisory Board for COMPASS Pathways.
The aim of the study is to carry out an assessment of a novel sleep enhancing food supplement for self-declared insomniacs based on both subjective and objective sleep measures, including residual effects.
Several conventional and over-the-counter sleep medications have residual effects and drowsiness. Psyched Wellness aims to develop new treatments that show a lack of residual hangover effects and increased alertness during the day.
Professor David Nutt, Board member and Head of the Company's Scientific Committee, said: "Psyched Wellness is researching the hugely important field of sleep and its disorders, and the Company's proprietary AME-1 has the potential to assist with these. Positive results from this clinical study will allow the Company to write a claim on the future AME-1 supplement that the product can help with sleep while also improving daytime functioning."
Professor David Nutt Will Lead This Study...
Only 16% gain today on that Huge news isn't too bad. Definitely heading in the right direction!
I've been continuing to nibble the .08 all along also. Sometimes I even get filled lower.
I sure hope so, I'm still adding...
the first 10k this morning. I just pay the ask!
I have to believe they will now commence a Major Marketing campaign.
Our time has Arrived!!!
It's nice big news but until they put it out
on PR Newswire nobody knows!
HUGE NEWS Psyched Wellness GRAS Dossier Approved by Panel of Experts, Providing Green Light to Market Products in the United States
https://www.newsfilecorp.com/release/115936/Psyched-Wellness-GRAS-Dossier-Approved-by-Panel-of-Experts-Providing-Green-Light-to-Market-Products-in-the-United-States
Usually... when a company announces that they are going to have a "Big Announcement" coming..... it doesn't live up to the hype.
So I'm hoping this Announcement will be the catalyst we've all been waiting for!
PSYCF
THIS BETTER BE BIG!!!$$$
A big announcement is coming soon.
— Psyched Wellness (@PsychedWellness) March 8, 2022
BOOOM The answer is Amanita Muscaria https://www.nationalgeographic.com/science/article/the-end-of-inflammation-new-approach-could-treat-dozens-of-diseases
MARCH 16, https://www.amanitadreamer.net/
BE THERE!
To be continued...
.
...
Psyched wellness Twitter is heating up! I'm thinking something big is about to come out. !!$$$$$
.
How most life on Earth is dependent on fungi – including you 👇🏼
— Psyched Wellness (@PsychedWellness) February 28, 2022
Read more:https://t.co/Eqn4z9IbTE$PSYC $PSYC.C pic.twitter.com/j4HYE5keQg
In an interview with @Proactive, CEO Jeff Stevens explains how our 90-day oral toxicity preclinical study on the Amanita Muscaria Extract (AME-1) is progressing.
— Psyched Wellness (@PsychedWellness) February 17, 2022
Watch below:https://t.co/zuGSf3PwNW$PSYC $PSYC.C #Mushrooms #psychedelic pic.twitter.com/HyftCCgedK
Followers
|
25
|
Posters
|
|
Posts (Today)
|
3
|
Posts (Total)
|
1286
|
Created
|
04/24/15
|
Type
|
Free
|
Moderators ListenToMe |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |